KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Current Deferred Revenue (2018 - 2025)

Historic Current Deferred Revenue for LifeMD (LFMD) over the last 8 years, with Q3 2025 value amounting to $14.4 million.

  • LifeMD's Current Deferred Revenue fell 3004.86% to $14.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.4 million, marking a year-over-year decrease of 3004.86%. This contributed to the annual value of $19.6 million for FY2024, which is 10209.37% up from last year.
  • According to the latest figures from Q3 2025, LifeMD's Current Deferred Revenue is $14.4 million, which was down 3004.86% from $11.8 million recorded in Q2 2025.
  • LifeMD's Current Deferred Revenue's 5-year high stood at $20.6 million during Q3 2024, with a 5-year trough of $1.3 million in Q1 2021.
  • Moreover, its 5-year median value for Current Deferred Revenue was $5.9 million (2023), whereas its average is $8.1 million.
  • As far as peak fluctuations go, LifeMD's Current Deferred Revenue skyrocketed by 35507.89% in 2021, and later tumbled by 3004.86% in 2025.
  • Quarter analysis of 5 years shows LifeMD's Current Deferred Revenue stood at $1.5 million in 2021, then soared by 269.86% to $5.5 million in 2022, then surged by 75.06% to $9.7 million in 2023, then skyrocketed by 102.09% to $19.6 million in 2024, then fell by 26.63% to $14.4 million in 2025.
  • Its Current Deferred Revenue stands at $14.4 million for Q3 2025, versus $11.8 million for Q2 2025 and $14.6 million for Q1 2025.